
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland 20892 [R. S., W-H. C., N. R.]; Division of Biostatistics, Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, Connecticut 06030 [M. K.]; and National Naval Medical Center, Bethesda, Maryland 20889 [J. D.]
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A group of compounds known as HCAs3 have been proposed as carcinogens. HCAs are formed in meats cooked at high temperature (10, 11, 12) and are potent mutagens and animal carcinogens (13, 14, 15, 16) ; however, the carcinogenic potential in humans has not been established (1) . Most human studies have used surrogates of HCAs, such as cooking techniques and doneness, rather than estimated values of the actual compounds of interest. HCA intake was estimated in a Swedish population-based case-control study of cancers of the colon, rectum, bladder, and kidney, but no association was observed with HCAs within the usual dietary range in this population (8) . However, there was evidence that HCAs may be carcinogenic at the extreme high end of intake because all of the subjects at this level were cases (8) .
To assess the risk of meat-cooking mutagens in the etiology of colorectal adenomas, we developed a meat-cooking module and HCA and mutagenic activity database (17, 18, 19, 20, 21) . We reported previously (22) that subjects were at a higher risk of colorectal adenomas if they consumed well-done red meat as compared with rare and medium-cooked meats. In this study, we evaluate the association between dietary intake of HCAs and mutagenic activity and risk of colorectal adenomas and explore to what extent these may explain our previously reported findings linking red meat and meat-cooking methods to this tumor.
| Materials and Methods |
|---|
|
|
|---|
HCA content (IQ, MeIQ, MeIQx, DiMeIQx, and PhIP) were determined in meat samples cooked by various methods to different degrees of doneness by the method of Gross and Gruter (23) using solid-phase extraction/high-performance liquid chromatography method. The mutagenic activity of the sample extracts were measured using the standard plate incorporation assay with Salmonella typhimurium strain TA98 with 2 mg of aroclor-induced rat liver S9 protein/plate for metabolic activation and tested in doses of 5, 10, 25, 50, and 100 µl. A positive control, 2-aminoanthracene, gave 8001200 revertants/µg. DMSO was included in the negative controls (spontaneous revertant counts) and gave TA98 values of 3045 revertant colonies/plate (20 , 24) .
The subjects completed a standard self-administered food frequency questionnaire (without the meat-cooking module) and an interviewer-administered meat-cooking module. For meats prepared with variable cooking techniques, we obtained information on the typical level of doneness and cooking method detailed in Sinha et al. (22) . We estimated intake of HCA and mutagenic activity using responses from the FFQ and the database that we developed for the HCA compounds and mutagenic activity in meat. First, by using frequency and portion size, we estimated gram consumption of each meat item (steak, hamburger patty, pork chops, bacon, etc.) by cooking technique and doneness level (verbal response and by photographs). Then, we derived intake of total HCA and mutagenic activity by multiplying grams of meat by concentration measured for each cooking technique/doneness level contribution for that meat type (17, 18, 19, 20, 21) . We also derived HCA values from red meat only, because PhIP content of grilled chicken can be variable (unpublished observation) and can add to misclassification for this HCA.
ORs and 95% CIs were computed using unconditional logistic regression (25) . The strength of association was determined for each HCA and mutagenic activity individually and then further adjusted for the other HCAs. Trend tests were calculated using intake variables as continuous data. All of the ORs were adjusted for age, gender, total caloric intake, fiber intake, reason for screening (routine or other), physical activity level, pack-years of cigarette smoking, and use of NSAIDs. In addition to these adjustment factors, each HCA was controlled for the others and for different types of meat groups.
| Results |
|---|
|
|
|---|
|
|
|
We examined colorectal adenoma risk with an estimate of total meat-derived mutagenic activity because it provides a biologically relevant and integrated measure of mutagenicity. We observed a strong increase in risk (P for trend, 0.0005; Fig. 1C
and Table 2
) associated with mutagenic activity from meat. Mutagenic activity remained significantly associated with increased risk even when adjusted for intake of red meat or well-done red meat (Table 2)
, previously shown to be associated with increased risk of colorectal adenomas. In contrast, the red meat and well-done red meat associations were no longer statistically significant when adjusted for total mutagenic activity. The association between mutagenic activity and risk of colorectal adenomas was minimally affected when adjusted for PhIP (which became nonsignificant) and was weakened when adjusted for MeIQx (which was attenuated to a much greater extent; Table 2
). Mutagenic activity is highly correlated with HCAs (Spearman correlation: mutagenic activity and PhIP, r = 0.65; mutagenic activity and MeIQx, r = 0.71).
| Discussion |
|---|
|
|
|---|
Total mutagenic activity is a biological measure that integrates all of the classes of mutagens according to their mutagenic potential. We believe that using total mutagenic activity is a superior measure compared with the sum of different HCAs. Adding individual HCAs does not take into account different mutagenic potentials of each compound and is weighted by the HCA that is the most abundant in meat, i.e., PhIP (which is the least mutagenic of the three HCAs most commonly found in cooked meats). In fact, because of the abundance of PhIP, the results of total HCAs and PhIP tend to be almost identical.
One of the main advantages of this case-control study was that it was specifically designed to investigate the role of HCAs and colorectal adenomas. We developed a HCA database (17, 18, 19, 20, 21) integrated with a detailed questionnaire on meat-cooking techniques. This questionnaire had details on key individual meat items, meat cooking, and doneness levels. We are in the process of validating the HCA intake estimated from this food frequency questionnaire using biomarkers (e.g., urinary HCA parent compounds and metabolites, and DNA- and protein-adducts) as well as multiple food diaries. Ultimately, the results presented in this report will need to be interpreted in the context of the validation study.
In the course of developing the database, we learned that it is crucial to obtain details on individual meat items such as beefsteak and beef roasts and not to combine these in the questionnaire because different cuts of meats are generally cooked by dissimilar methods, and levels of HCAs vary dramatically. We also found that the high temperature cooking methods needed to be separated because different amounts of HCAs are produced by frying, grilling, and broiling attributable to the way meat cooks. In frying, the heat source is in contact with the bottom of the meat surface, so that the juices with the precursors of HCAs are in contact with it. In broiling, the heat source is above the meat surface, and the juices with the precursors drip away from the meat and heat source. In grilling, the heat source is below the meat, with fat dripping onto the heated surface causing flashing of flames and intermittent contact of meat surface with very high temperatures.
The cases had adenomas rather than cancer and, thus, were less likely to have changed their current dietary habits after diagnosis. Furthermore, their responses to questions about usual dietary habits were less likely to be influenced by their treatment. Even with intensive biological components, with both a clinic and a home component, the participation rates were relatively high for this study. Finally, cases and controls were recruited from a well-defined base of individuals.
One of the limitations for this study was that we interviewed subjects after their diagnostic and treatment procedures so there is potential for recall bias, but this is likely to be less of a problem when studying precancerous tumors as compared with cancer. Furthermore, cases had a colonoscopy, whereas the controls had only a sigmoidoscopy; therefore, some controls might have had undetected adenomas in the right side of the colon. But, when analysis was restricted to cases with left-sided colon adenomas detectable by sigmoidoscopy, the results were essentially unchanged.
Our results are consistent with animal carcinogenicity studies of HCAs, which have consistently found increased gastrointestinal tumor production with high intake of specific HCAs (26, 27, 28) . In humans, only one study, conducted in Sweden, has investigated directly the role of HCAs in the etiology of colon and rectal cancers. This study did not find risk associated within the usual dietary range of HCA intake in the study population, but they did observe increased risk associated at the extreme end of the daily intake (8) . In our study, we find risk associated with MeIQx and possibly PhIP, mainly in the top quintiles.
We and other investigators in Japan, New Zealand, and various countries in Europe, North America, and South America are actively pursuing the meat cooking, HCA-cancer hypothesis in ongoing prospective and case-control studies of cancers that are known targets for HCA carcinogenicity in animal studies (e.g., breast, prostate, and gastrointestinal tract). Over the next few years, these studies should shed more light on the carcinogenicity of HCAs in humans.
| Acknowledgments |
|---|
| Footnotes |
|---|
1 The opinions and assertions contained herein are the sole views of the authors and should not be construed as official or affecting the views of the Department of the Navy, Department of Defense, or the United States Government. The Chief, Navy Bureau of Medicine and Surgery, Washington, D. C., Clinical Investigations Program sponsored this study (B93-004). ![]()
2 To whom requests for reprints should be addressed, at Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Executive Plaza North, Room 443, 6130 Executive Boulevard, Rockville, MD 20892. ![]()
3 The abbreviations used are: HCA, heterocyclic amine; MeIQx, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline; DiMeIQx, 2-amino-3,4,8-trimethylimidazo-[4,5-f]quinoxaline; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; IQ, 2- amino-3-methylimidazo[4,5-f]quinoline; MeIQ, 2-amino-3,4-dimethylimidazo-[4,5-f]quinoline; OR, odds ratio; CI, confidence interval; NSAID, nonsteroidal anti-inflammatory drug. ![]()
Received 6/ 9/00; revised 1/25/01; accepted 2/ 5/01.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
U. Nothlings, J. F. Yamamoto, L. R. Wilkens, S. P. Murphy, S.-Y. Park, B. E. Henderson, L. N. Kolonel, and L. Le Marchand Meat and Heterocyclic Amine Intake, Smoking, NAT1 and NAT2 Polymorphisms, and Colorectal Cancer Risk in the Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2098 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rohrmann, S. Hermann, and J. Linseisen Heterocyclic aromatic amine intake increases colorectal adenoma risk: findings from a prospective European cohort study Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1418 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Cross, M. F. Leitzmann, A. F. Subar, F. E. Thompson, A. R. Hollenbeck, and A. Schatzkin A Prospective Study of Meat and Fat Intake in Relation to Small Intestinal Cancer Cancer Res., November 15, 2008; 68(22): 9274 - 9279. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Feng, J. R. Neale, M. A. Doll, and D. W. Hein Chemoprevention of Arylamine-Induced Colorectal Aberrant Crypts Experimental Biology and Medicine, January 1, 2008; 233(1): 71 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Martinez, E. T. Jacobs, E. L. Ashbeck, R. Sinha, P. Lance, D. S. Alberts, and P. A. Thompson Meat intake, preparation methods, mutagens and colorectal adenoma recurrence Carcinogenesis, September 1, 2007; 28(9): 2019 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bendaly, S. Zhao, J. R. Neale, K. J. Metry, M. A. Doll, J. C. States, W. M. Pierce Jr., and D. W. Hein 2-Amino-3,8-Dimethylimidazo-[4,5-f]Quinoxaline-Induced DNA Adduct Formation and Mutagenesis in DNA Repair-Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-Acetyltransferase 2 Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1503 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Ward, A. J. Cross, H. Divan, M. Kulldorff, S. Nowell-Kadlubar, F. F. Kadlubar, and R. Sinha Processed meat intake, CYP2A6 activity and risk of colorectal adenoma Carcinogenesis, June 1, 2007; 28(6): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, J. J. Liu, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, N. L. Nock, J. J. Yang, and B. A. Rybicki Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 803 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakai, W. G. Nelson, and A. M. De Marzo The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Acts as Both a Tumor Initiator and Promoter in the Rat Ventral Prostate Cancer Res., February 1, 2007; 67(3): 1378 - 1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Galeone, R Talamini, F Levi, C Pelucchi, E Negri, A Giacosa, M Montella, S Franceschi, and C La Vecchia Fried foods, olive oil and colorectal cancer Ann. Onc., January 1, 2007; 18(1): 36 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Malfatti, K. H. Dingley, S. Nowell-Kadlubar, E. A. Ubick, N. Mulakken, D. Nelson, N. P. Lang, J. S. Felton, and K. W. Turteltaub The Urinary Metabolite Profile of the Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Is Predictive of Colon DNA Adducts after a Low-Dose Exposure in Humans Cancer Res., November 1, 2006; 66(21): 10541 - 10547. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, E. Giovannucci, C. Byrne, E. A. Platz, C. Fuchs, W. C. Willett, and R. Sinha Meat mutagens and risk of distal colon adenoma in a cohort of u.s. Men. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1120 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Cross, U. Peters, V. A. Kirsh, G. L. Andriole, D. Reding, R. B. Hayes, and R. Sinha A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk Cancer Res., December 15, 2005; 65(24): 11779 - 11784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Malfatti, E. A. Ubick, and J. S. Felton The impact of glucuronidation on the bioactivation and DNA adduction of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in vivo Carcinogenesis, November 1, 2005; 26(11): 2019 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sinha, U. Peters, A. J. Cross, M. Kulldorff, J. L. Weissfeld, P. F. Pinsky, N. Rothman, R. B. Hayes, and Prostate, Lung, Colorectal, and Ovarian Cancer Pro Meat, Meat Cooking Methods and Preservation, and Risk for Colorectal Adenoma Cancer Res., September 1, 2005; 65(17): 8034 - 8041. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sinha, M. Kulldorff, M. J. Gunter, P. Strickland, and N. Rothman Dietary Benzo[a]Pyrene Intake and Risk of Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2030 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Moore, W.-Y. Huang, N. Chatterjee, M. Gunter, S. Chanock, M. Yeager, B. Welch, P. Pinsky, J. Weissfeld, and R. B. Hayes GSTM1, GSTT1, and GSTP1 Polymorphisms and Risk of Advanced Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1823 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gunter, N. M. Probst-Hensch, V. K. Cortessis, M. Kulldorff, R. W. Haile, and R. Sinha Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study Carcinogenesis, March 1, 2005; 26(3): 637 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kikugawa Prevention of mutagen formation in heated meats and model systems Mutagenesis, November 1, 2004; 19(6): 431 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cantwell, B. Mittl, J. Curtin, R. Carroll, N. Potischman, N. Caporaso, and R. Sinha Relative Validity of a Food Frequency Questionnaire with a Meat-Cooking and Heterocyclic Amine Module Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 293 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, D. M. DeMarini, R. Sinha, L. R. Brooks, S. H. Warren, N. Chatterjee, and N. Rothman Urinary Mutagenicity and Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1253 - 1256. [Abstract] [Full Text] |
||||
![]() |
M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Mirvish, J. Haorah, L. Zhou, M. Hartman, C. R. Morris, and M. L. Clapper N-Nitroso compounds in the gastrointestinal tract of rats and in the feces of mice with induced colitis or fed hot dogs or beef Carcinogenesis, March 1, 2003; 24(3): 595 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Butler, R. Sinha, R. C. Millikan, C. F. Martin, B. Newman, M. D. Gammon, A. S. Ammerman, and R. S. Sandler Heterocyclic Amines, Meat Intake, and Association with Colon Cancer in a Population-based Study Am. J. Epidemiol., March 1, 2003; 157(5): 434 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Diergaarde, W. L. van Geloof, G. N.P. van Muijen, F. J. Kok, and E. Kampman Dietary factors and the occurrence of truncating APC mutations in sporadic colon carcinomas: a Dutch population-based study Carcinogenesis, February 1, 2003; 24(2): 283 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boyle and M. E. Leon Epidemiology of colorectal cancer Br. Med. Bull., December 1, 2002; 64(1): 1 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seow, J.-M. Yuan, C.-L. Sun, D. Van Den Berg, H.-P. Lee, and M. C. Yu Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study Carcinogenesis, December 1, 2002; 23(12): 2055 - 2061. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |